Literature DB >> 11042206

The nonsense-mediated decay pathway and mutually exclusive expression of alternatively spliced FGFR2IIIb and -IIIc mRNAs.

R B Jones1, F Wang, Y Luo, C Yu, C Jin, T Suzuki, M Kan, W L McKeehan.   

Abstract

Exons IIIb and IIIc of the FGFR2 gene are alternatively spliced in a mutually exclusive manner in different cell types. A switch from expression of FGFR2IIIb to FGFR2IIIc accompanies the transition of nonmalignant rat prostate tumor epithelial cells (DTE) to cells comprising malignant AT3 tumors. Here we used transfection of minigenes with and without alterations in reading frame and with and without introns to examine how translation affects observed FGFR2 splice products. We observed that nonsense mutations in other than the last exon led to a dramatic reduction in mRNA that is abrogated by removal of downstream introns in both DTE and AT3 cells. The mRNA, devoid of both IIIb and IIIc exons (C1-C2), is a major splice product from minigenes lacking an intron downstream of the second common exon C2. From these observations, we suggest that repression of exon IIIc and activation of exon IIIb inclusion in DTE cells lead to the generation of both C1-IIIb-C2 and C1-C2 products. However, the C1-C2 product from the native gene is degraded due to a frameshift and a premature termination codon caused by splicing C1 and C2 together. Derepression of exon IIIc and repression of exon IIIb lead to the generation of both C1-IIIc-C2 and C1-C2 products in AT3 cells, but the C1-C2 product is degraded. The C1-IIIb-IIIc-C2 mRNA containing a premature termination codon in exon IIIc was present, but at apparently trace levels in both cell types. The nonsense-mediated mRNA decay pathway and cell type-dependent rates of inclusion of exons IIIb and IIIc result in the mutually exclusive expression of FGFR2IIIb and IIIc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042206     DOI: 10.1074/jbc.M006151200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Concentration-dependent control of pyruvate kinase M mutually exclusive splicing by hnRNP proteins.

Authors:  Mo Chen; Charles J David; James L Manley
Journal:  Nat Struct Mol Biol       Date:  2012-02-05       Impact factor: 15.369

2.  Mutually exclusive splicing of the insect Dscam pre-mRNA directed by competing intronic RNA secondary structures.

Authors:  Brenton R Graveley
Journal:  Cell       Date:  2005-10-07       Impact factor: 41.582

3.  Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.

Authors:  Emily A Newman; Stephanie J Muh; Ruben H Hovhannisyan; Claude C Warzecha; Richard B Jones; Wallace L McKeehan; Russ P Carstens
Journal:  RNA       Date:  2006-04-07       Impact factor: 4.942

4.  Expression of two novel alternatively spliced COL2A1 isoforms during chondrocyte differentiation.

Authors:  Audrey McAlinden; Brian Johnstone; John Kollar; Najam Kazmi; Thomas M Hering
Journal:  Matrix Biol       Date:  2007-10-18       Impact factor: 11.583

5.  STAR family RNA-binding protein ASD-2 regulates developmental switching of mutually exclusive alternative splicing in vivo.

Authors:  Genta Ohno; Masatoshi Hagiwara; Hidehito Kuroyanagi
Journal:  Genes Dev       Date:  2008-01-29       Impact factor: 11.361

6.  Alternative splicing mechanisms orchestrating post-transcriptional gene expression: intron retention and the intron-rich genome of apicomplexan parasites.

Authors:  Matteo Lunghi; Furio Spano; Alessandro Magini; Carla Emiliani; Vern B Carruthers; Manlio Di Cristina
Journal:  Curr Genet       Date:  2015-07-21       Impact factor: 3.886

Review 7.  Signaling from novel splice variants of hormone receptors in cancer.

Authors:  Wei-Qun Ding; Laurence J Miller
Journal:  Int J Gastrointest Cancer       Date:  2002

8.  5'- and 3'-terminal nucleotides in the FGFR2 ISAR splicing element core have overlapping roles in exon IIIb activation and exon IIIc repression.

Authors:  R B Jones; R P Carstens; Y Luo; W L McKeehan
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

Review 9.  Complex alternative splicing.

Authors:  Jung Woo Park; Brenton R Graveley
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

10.  Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease.

Authors:  Heike Steiling; Marcus Mühlbauer; Frauke Bataille; Jürgen Schölmerich; Sabine Werner; Claus Hellerbrand
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.